SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-040222
Filing Date
2023-03-31
Accepted
2023-03-31 16:29:23
Documents
7
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2310897d1_s8.htm S-8 81742
2 EXHIBIT 5.1 tm2310897d1_ex5-1.htm EX-5.1 11800
3 EXHIBIT 23.1 tm2310897d1_ex23-1.htm EX-23.1 1891
4 EXHIBIT 23.2 tm2310897d1_ex23-2.htm EX-23.2 1989
5 EX-FILING FEES tm2310897d1_ex-filingfees.htm EX-FILING FEES 12425
6 GRAPHIC tm2310897d1_ex5-1img01.jpg GRAPHIC 8602
7 GRAPHIC tm2310897d1_ex5-1img02.jpg GRAPHIC 2551
  Complete submission text file 0001104659-23-040222.txt   126863
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271035 | Film No.: 23788216
SIC: 2836 Biological Products, (No Diagnostic Substances)